Hasbro, Inc 8-K, filed Aug 20, 2020
Hasbro, Inc. (HAS)
8-K
2020-08-20
For: 2020-08-20
View Original
Added on
April 09, 2026
About this 8-K
Hasbro, Inc filed this 8-K on August 20, 2020.
Items reported
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 20, 2020
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code: (401 ) 431-8697
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act.
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the
Securities Exchange Act of 1934.
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period provided pursuant to Section
13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
On August 20, 2020, Brian D. Goldner, Chairman and Chief Executive Officer of Hasbro, Inc. (“Hasbro”), sent an email to Hasbro
employees informing them of a course of medical treatment he is receiving. A copy of his email is attached as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
| HASBRO, INC. | ||||
|
|
By:
|
/s/ Deborah Thomas | ||
| Name: | Deborah Thomas | |||
| Title: |
Executive Vice President and Chief Financial Officer
(Duly Authorized Officer and Principal Financial Officer)
|
|||
| Date: August 20, 2020 | ||||
Exhibit 99.1
|
To:
|
Global Employees
|
|
From:
|
Brian Goldner
|
|
Date:
|
August 20, 2020
|
|
RE:
|
Update from Brian Goldner
|
To my friends and colleagues at Hasbro,
I wanted you all to know that I am receiving a course of medical treatment subsequent to one of my recent follow-up doctor’s appointments. I have had these follow-up
appointments regularly since my treatment in 2014. The course of medication I am receiving now may cause me to lose my hair for a brief period of time.
I’m feeling great, the doctors say my prognosis is excellent and I plan to continue to actively fulfill my duties and responsibilities as Hasbro’s Chairman and CEO without
interruption. I have discussed this with Hasbro’s Board of Directors who have been extremely supportive.
I appreciate your partnership as we continue to build Hasbro into the leading global play and entertainment company, and look forward to seeing you either virtually on
Teams or in the office soon.
Best,
bg